Bosh sahifa068270 ā¢ KRX
add
Celltrion Inc
Yopilish kursi
160Ā 500,00Ā ā©
Kunlik diapazon
160Ā 200,00Ā ā© - 163Ā 400,00Ā ā©
Yillik diapazon
150Ā 400,00Ā ā© - 200Ā 952,39Ā ā©
Bozor kapitalizatsiyasi
36,28Ā trln KRW
OŹ»rtacha hajm
460,25Ā ming
Narx/foyda
61,82
Dividend daromadliligi
0,44%
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 841,91Ā mlrd | 14,24% |
Joriy xarajat | 293,45Ā mlrd | 0,76% |
Sof foyda | 108,67Ā mlrd | 384,28% |
Sof foyda marjasi | 12,91 | 324,67% |
Har bir ulushga tushum | 529,00 | 414,31% |
EBITDA | 220,36Ā mlrd | 49,86% |
Amaldagi soliq stavkasi | 44,58% | ā |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 970,72Ā mlrd | 5,45% |
Jami aktivlari | 20,96Ā trln | 4,00% |
Jami passivlari | 3,68Ā trln | 16,94% |
Umumiy kapital | 17,28Ā trln | ā |
Tarqatilgan aksiyalar | 224,61Ā mln | ā |
Narxi/balansdagi bahosi | 2,10 | ā |
Aktivlardan daromad | 1,78% | ā |
Kapitaldan daromad | 1,90% | ā |
Pul aylanmasi
Naqd pulning sof oŹ»zgarishi
| (KRW) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 108,67Ā mlrd | 384,28% |
Operatsiyalardan naqd pul | 113,45Ā mlrd | 206,45% |
Sarmoyadan naqd pul | -54,86Ā mlrd | -55,15% |
Moliyadan naqd pul | -243,49Ā mlrd | -242,88% |
Naqd pulning sof oŹ»zgarishi | -167,36Ā mlrd | -191,58% |
BoŹ»sh pul | 226,51Ā mlrd | 169,09% |
Haqida
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
CEO
Tashkil etilgan
2002
Sayt
Xodimlar soni
2Ā 391
